Free tool
FAERS Monitor: Bactrim
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017560 or its brand name (Bactrim, Sulfamethoxazole, Trimethoprim). Reports on generic versions are filed under their own applications.
Reports
70,110
Serious
59,125
84% of reports
Hospitalization
36,570
Death reported
8,738
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pyrexia5,541
- off label use4,378
- fatigue4,197
- diarrhoea4,079
- rash3,910
- nausea3,787
- dyspnoea3,613
- pain3,410
- drug ineffective3,258
- vomiting3,184
- drug hypersensitivity2,987
- pneumonia2,728
- pruritus2,727
- acute kidney injury2,690
- headache2,665
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 794 |
| 2005 | 844 |
| 2006 | 907 |
| 2007 | 1,079 |
| 2008 | 1,366 |
| 2009 | 1,512 |
| 2010 | 1,574 |
| 2011 | 2,063 |
| 2012 | 2,088 |
| 2013 | 1,567 |
| 2014 | 2,023 |
| 2015 | 3,264 |
| 2016 | 3,943 |
| 2017 | 4,059 |
| 2018 | 5,403 |
| 2019 | 6,015 |
| 2020 | 5,698 |
| 2021 | 5,120 |
| 2022 | 4,485 |
| 2023 | 4,440 |
| 2024 | 4,849 |
| 2025 | 4,072 |
| 2026 | 2,940 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,984,049 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 2,690 | 5.3 | 5.2 | 9,411 |
| pyrexiaSignal | 5,541 | 4.9 | 4.7 | 17,023 |
| drug hypersensitivitySignal | 2,987 | 4.7 | 4.5 | 8,606 |
| rashSignal | 3,910 | 2.7 | 2.6 | 4,255 |
| pneumoniaSignal | 2,728 | 2.5 | 2.4 | 2,565 |
| pruritusSignal | 2,727 | 2.1 | 2.1 | 1,667 |
| vomitingSignal | 3,184 | 2.0 | 2.0 | 1,711 |
| dyspnoea | 3,613 | 1.9 | 1.9 | 1,627 |
| diarrhoea | 4,079 | 1.9 | 1.8 | 1,786 |
| pain | 3,410 | 1.7 | 1.6 | 936 |
| fatigue | 4,197 | 1.6 | 1.6 | 1,029 |
| off label use | 4,378 | 1.5 | 1.5 | 763 |
| nausea | 3,787 | 1.4 | 1.4 | 521 |
| headache | 2,665 | 1.3 | 1.2 | 163 |
| drug ineffective | 3,258 | 0.7 | 0.7 | 314 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.